US › Healthcare

Eocene Ltd. (EOCN)

US · Healthcare · Biotechnology

$2.85-6.56%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.7M

EPS

$-2.86

EPS estimate

$-3.12

EPS came in at -2.86 against a street estimate of -3.12 — a beat of 8.3%.

Key statistics

Market cap

$3.3M

Forward P/E

0.0

P/B

0.30

Book value

$12.72

EPS (TTM)

$-14.47

52-week high

$12.32

52-week low

$2.33

50-day MA

$3.92

200-day MA

$4.80

Beta

0.66

Analyst view

Analysts rate Eocene Ltd. a hold (0 buy, 1 hold, 0 sell out of 1).

Shareholding

Insiders

3.04%

Institutions

1.89%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.04%
HRT FINANCIAL LLC	0.51%
XTX Topco Ltd	0.18%
TWO SIGMA SECURITIES, LLC	0.13%
Royal Bank of Canada	0.01%
Morgan Stanley - Brokerage Accounts	0.00%
SBI Securities Co Ltd	0.00%
Wells Fargo & Co	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Eocene Ltd. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.